Search

everythinglearnresearchcommunity

for

Search:↓

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

SHBG may be a useful early indicator and treatment target for PCOS.

Antidepressants called SSRIs can cause skin problems, bleeding risk, and other side effects.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

St. John's Wort can cause dangerous high blood pressure if taken with certain foods.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Minoxidil can cause dangerous fluid buildup around the heart.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.